GLP-1 Receptor Agonist Market Expected to Expand with Increasing Obesity Treatment Adoption

The global GLP-1 receptor agonist market is entering a phase of unprecedented expansion, driven by the rising prevalence of type 2 diabetes mellitus and obesity, growing awareness of metabolic health, and rapid innovation in pharmaceutical research. ...